|
| | | An Act To Ensure Disclosure of Prescription Drug Prices |
|
| | | Be it enacted by the People of the State of Maine as follows: |
|
| | | Sec. 1. 22 MRSA §2698-B is enacted to read: |
|
| | | §2698-B.__Actual price disclosure and certification |
|
| | | 1.__Quarterly report.__A manufacturer of prescription drugs | | dispensed in this State under a health program directed or | | administered by the State shall, on a quarterly basis, report by | | National Drug Code the following pharmaceutical pricing criteria | | to the commissioner for each of its drugs: |
|
| | | A.__The average wholesale price; |
|
| | | B.__The wholesale acquisition cost; |
|
| | | C.__The average manufacturer price as defined in 42 United | | States Code, Section 1396r-8(k); and |
|
| | | D.__The best price as defined in 42 United States Code, | | Section 1396r-8(c)(1)(C). |
|
| | | 2.__Calculation.__The calculation of average wholesale price | | and wholesale acquisition cost must be the net of all volume | | discounts, prompt payment discounts, charge-backs, short-dated | | product discounts, cash discounts, free goods, rebates and all | | other price concessions or incentives provided to a purchaser |
|
|
